In addition to their potent vasoconstrictor properties, the endothelin
s (endothelin-l and -3) may possess neurotransmitter/neuromediator and
neuroendocrine actions. The aim of the present study was to evaluate
the role of endothelins (ET) in mediating neurogenic inflammation of c
ephalic tissues in the rat. For this purpose, bosentan, a specific non
-peptide mixed antagonist of ET receptors, was tested in rat models of
neurogenic and non-neurogenic plasma extravasation in the dura mater
and extracranial tissues (eyelid, conjunctiva, lip, tongue). Bosentan
was effective for preventing neurogenic inflammation in the dura mater
induced by unilateral electrical stimulation of the trigeminal gangli
on or intravenous injection of capsaicin, whereas it was ineffective i
n extracranial tissues or after injection of substance P (non-neurogen
ic inflammation). The effect of nerve fiber stimulation on ET plasma c
oncentrations in superior sagittal sinus was measured using selective
radioimmunoassays for ET-1 and -3. Endothelin-3 concentration signific
antly increased after intravenous injection of capsaicin, whereas ET-1
levels remained unchanged. Competition binding assays on microsomal m
embranes from the trigeminal ganglion revealed a single class of bindi
ng sites with equal affinity for ET-1 and ET-3, suggesting a homogenou
s population of ET receptors. The role of ET(B) receptors in mediating
inflammation was evidenced by the lack of efficacy of a selective ET(
A) receptor antagonist, in contrast to the full efficacy of a selectiv
e ET(B) receptor antagonist, for preventing neurogenic inflammation in
duced by unilateral stimulation of the trigeminal ganglion. The role o
f ET(B) receptors was finally confirmed by the observation that exogen
ous administration of the ET(B) receptor agonist sarafotoxin S6c also
induced plasma protein extravasation in the dura mater. This extravasa
tion was not a direct effect of ET(B) receptor stimulation, because it
was inhibited by spantide, a selective tachykinin receptor antagonist
. These data strongly suggest that ET, acting through ET(B) receptors,
may play an important role in mediating neurogenic inflammation in th
e meninges of rats. Since the profile of activity of bosentan is simil
ar to that of the 5-HTID/B agonists, sumatriptan and ergot alkaloids,
one may speculate that ET receptor antagonists might be potentially ef
fective in the treatment of acute migraine attacks.